Literature DB >> 28699539

Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.

Ada Pesapane1, Pia Ragno2, Carmine Selleri3, Nunzia Montuori1.   

Abstract

The 67 kDa high affinity laminin receptor (67LR) is a non-integrin cell surface receptor for laminin, the major component of basement membranes. Interactions between 67LR and laminin play a major role in mediating cell adhesion, migration, proliferation and survival. 67LR derives from homo- or hetero-dimerization of a 37 kDa cytosolic precursor (37LRP), most probably by fatty acid acylation. Interestingly, 37LRP, also called p40 or OFA/iLR (oncofetal antigen/immature laminin receptor), is a multifunctional protein with a dual activity in the cytoplasm and in the nucleus. In the cytoplasm, 37LRP it is associated with the 40S subunit of ribosome, playing a critical role in protein translation and ribosome biogenesis while in the nucleus it is tightly associated with nuclear structures, and bound to components of the cytoskeleton, such as tubulin and actin. 67LR is mainly localized in the cell membrane, concentrated in lipid rafts. Acting as a receptor for laminin is not the only function of 67LR; indeed, it also acts as a receptor for viruses, bacteria and prions. 67LR expression is increased in neoplastic cells and correlates with an enhanced invasive and metastatic potential. The primary function of 67LR in cancer is to promote tumor cell adhesion to basement membranes, the first step in the invasion-metastasis cascade. Thus, 67LR is overexpressed in neoplastic cells as compared to their normal counterparts and its overexpression is considered a molecular marker of metastatic aggressiveness in cancer of many tissues, including breast, lung, ovary, prostate, stomach, thyroid and also in leukemia and lymphoma. Thus, inhibiting 67LR binding to laminin could be a feasible approach to block cancer progression. Here, we review the current understanding of the structure and function of this molecule, highlighting its role in cancer invasion and metastasis and reviewing the various therapeutic options targeting this receptor that could have a promising future application. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Laminin receptor; laminin; leukemia; metastasis; monoclonal antibody; small molecule

Mesh:

Substances:

Year:  2017        PMID: 28699539     DOI: 10.2174/1381612823666170710125332

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

1.  37/67-laminin receptor facilitates neural crest cell migration during enteric nervous system development.

Authors:  Ming Fu; Amanda J Barlow-Anacker; Korah P Kuruvilla; Gary L Bowlin; Christopher W Seidel; Paul A Trainor; Ankush Gosain
Journal:  FASEB J       Date:  2020-06-27       Impact factor: 5.191

Review 2.  The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review.

Authors:  Elena Ferrari; Saverio Bettuzzi; Valeria Naponelli
Journal:  Int J Mol Sci       Date:  2022-05-28       Impact factor: 6.208

3.  An adiponectin paralog protein, CTRP6 decreased the proliferation and invasion activity of oral squamous cell carcinoma cells: possible interaction with laminin receptor pathway.

Authors:  Kimika Hano; Kiichi Hatano; Chiemi Saigo; Yusuke Kito; Toshiyuki Shibata; Tamotsu Takeuchi
Journal:  Mol Biol Rep       Date:  2019-06-28       Impact factor: 2.316

4.  Epigallocatechin Gallate-Gold Nanoparticles Exhibit Superior Antitumor Activity Compared to Conventional Gold Nanoparticles: Potential Synergistic Interactions.

Authors:  Suhash Reddy Chavva; Sachin Kumar Deshmukh; Rajashekhar Kanchanapally; Nikhil Tyagi; Jason William Coym; Ajay Pratap Singh; Seema Singh
Journal:  Nanomaterials (Basel)       Date:  2019-03-08       Impact factor: 5.076

5.  Coptisine Induces Apoptosis in Human Hepatoma Cells Through Activating 67-kDa Laminin Receptor/cGMP Signaling.

Authors:  Li Zhou; Fan Yang; Guobing Li; Jingbin Huang; Yali Liu; Qian Zhang; Qin Tang; Changpeng Hu; Rong Zhang
Journal:  Front Pharmacol       Date:  2018-05-18       Impact factor: 5.810

6.  MicroRNA-587 Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting Ribosomal Protein SA.

Authors:  Miao Chen; Duo Wang; Junjie Liu; Zhizhan Zhou; Zhanling Ding; Lianfeng Liu; Danke Su; Hang Li
Journal:  Biomed Res Int       Date:  2020-09-05       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.